Cerwenka A - Search Results

1

Human innate immune cell crosstalk induces melanoma cell senescence.

Funck F, Pahl J, Kyjacova L, Freund L, Oehrl S, Gräbe G, Pezer S, Hassel JC, Sleeman J, Cerwenka A, Schäkel K. Funck F, et al. Among authors: cerwenka a. Oncoimmunology. 2020 Aug 30;9(1):1808424. doi: 10.1080/2162402X.2020.1808424. Oncoimmunology. 2020. PMID: 32939325 Free PMC article.

2

Natural killer cells and solid tumors.

Stojanovic A, Cerwenka A. Stojanovic A, et al. Among authors: cerwenka a. J Innate Immun. 2011;3(4):355-64. doi: 10.1159/000325465. Epub 2011 Apr 18. J Innate Immun. 2011. PMID: 21502747 Free article. Review.

3

Tricking the balance: NK cells in anti-cancer immunity.

Pahl J, Cerwenka A. Pahl J, et al. Among authors: cerwenka a. Immunobiology. 2017 Jan;222(1):11-20. doi: 10.1016/j.imbio.2015.07.012. Epub 2015 Jul 26. Immunobiology. 2017. PMID: 26264743 Review.

4

The HMGB1 protein induces a metabolic type of tumour cell death by blocking aerobic respiration.

Gdynia G, Sauer SW, Kopitz J, Fuchs D, Duglova K, Ruppert T, Miller M, Pahl J, Cerwenka A, Enders M, Mairbäurl H, Kamiński MM, Penzel R, Zhang C, Fuller JC, Wade RC, Benner A, Chang-Claude J, Brenner H, Hoffmeister M, Zentgraf H, Schirmacher P, Roth W. Gdynia G, et al. Among authors: cerwenka a. Nat Commun. 2016 Mar 7;7:10764. doi: 10.1038/ncomms10764. Nat Commun. 2016. PMID: 26948869 Free PMC article.

5

Highly efficient IL-21 and feeder cell-driven ex vivo expansion of human NK cells with therapeutic activity in a xenograft mouse model of melanoma.

Granzin M, Stojanovic A, Miller M, Childs R, Huppert V, Cerwenka A. Granzin M, et al. Among authors: cerwenka a. Oncoimmunology. 2016 Aug 5;5(9):e1219007. doi: 10.1080/2162402X.2016.1219007. eCollection 2016. Oncoimmunology. 2016. PMID: 27757317 Free PMC article.

6

MicroRNA-519a-3p mediates apoptosis resistance in breast cancer cells and their escape from recognition by natural killer cells.

Breunig C, Pahl J, Küblbeck M, Miller M, Antonelli D, Erdem N, Wirth C, Will R, Bott A, Cerwenka A, Wiemann S. Breunig C, et al. Among authors: cerwenka a. Cell Death Dis. 2017 Aug 3;8(8):e2973. doi: 10.1038/cddis.2017.364. Cell Death Dis. 2017. PMID: 28771222 Free PMC article.

7

KIR downregulation by IL-12/15/18 unleashes human NK cells from KIR/HLA-I inhibition and enhances killing of tumor cells.

Ewen EM, Pahl JHW, Miller M, Watzl C, Cerwenka A. Ewen EM, et al. Among authors: cerwenka a. Eur J Immunol. 2018 Feb;48(2):355-365. doi: 10.1002/eji.201747128. Epub 2017 Nov 29. Eur J Immunol. 2018. PMID: 29105756 Free article.

8

CD16A Activation of NK Cells Promotes NK Cell Proliferation and Memory-Like Cytotoxicity against Cancer Cells.

Pahl JHW, Koch J, Götz JJ, Arnold A, Reusch U, Gantke T, Rajkovic E, Treder M, Cerwenka A. Pahl JHW, et al. Among authors: cerwenka a. Cancer Immunol Res. 2018 May;6(5):517-527. doi: 10.1158/2326-6066.CIR-17-0550. Epub 2018 Mar 7. Cancer Immunol Res. 2018. PMID: 29514797

9

Distinct human circulating NKp30⁺FcεRIγ⁺CD8⁺ T cell population exhibiting high natural killer-like antitumor potential.

Correia MP, Stojanovic A, Bauer K, Juraeva D, Tykocinski LO, Lorenz HM, Brors B, Cerwenka A. Correia MP, et al. Among authors: cerwenka a. Proc Natl Acad Sci U S A. 2018 Jun 26;115(26):E5980-E5989. doi: 10.1073/pnas.1720564115. Epub 2018 Jun 12. Proc Natl Acad Sci U S A. 2018. PMID: 29895693 Free PMC article.

10

Memory-Like NK Cells: Remembering a Previous Activation by Cytokines and NK Cell Receptors.

Pahl JHW, Cerwenka A, Ni J. Pahl JHW, et al. Among authors: cerwenka a. Front Immunol. 2018 Nov 28;9:2796. doi: 10.3389/fimmu.2018.02796. eCollection 2018. Front Immunol. 2018. PMID: 30546366 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

132 results

Search Page